AVADEL PHARMACEUTICALS PLC (AVDL)
Institutional ownership reported to the SEC as of Q1 2026, across 10 quarters.
1
Reporting holders
$426
Reported value
0.0%
Held as options
-194
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| IFP Advisors, Inc | $426 | 20 | 0.00% | 6q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2026 | 1 | $426 | 20 | 0 | 0 | 0 | 0.0% |
| Q4 2025 | 195 | $1.7B | 72,193,718 | 62 | 38 | 66 | 8.5% |
| Q3 2025 | 175 | $1.3B | 79,264,860 | 34 | 52 | 54 | 4.0% |
| Q2 2025 | 158 | $710.6M | 79,599,659 | 24 | 58 | 49 | 0.9% |
| Q1 2025 | 164 | $602.7M | 75,876,707 | 38 | 54 | 41 | 1.0% |
| Q4 2024 | 150 | $862.5M | 78,470,914 | 19 | 61 | 37 | 4.4% |
| Q3 2024 | 168 | $1.0B | 72,947,884 | 44 | 49 | 40 | 8.1% |
| Q2 2024 | 142 | $981.9M | 66,747,339 | 138 | 1 | 2 | 4.4% |
| Q1 2024 | 7 | $36.6M | 2,166,772 | 7 | 0 | 0 | 0.0% |
| Q1 2023 | 1 | $4.3K | 468 | 1 | 0 | 0 | 0.0% |